Taltz, on the other hand, works by precisely targeting and blocking a specific immune system protein, IL-17A, that causes inflammation in certain autoimmune diseases
Important questions include Whether long term use is anticipated What is known about discontinuation How maintenance is approached if therapy changes Follow up analyses from randomized controlled trials show that discontinuing GLP 1 therapy is commonly associated with a return toward baseline weight or metabolic set point
And for people with acid reflux, food staying in the stomach longer could increase the number and severity of symptoms
Because liraglutide is taken daily, you have more flexibility to adjust doses day by day if needed
Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrin M, et al